←Back to Expert Scholars
Translational Medicine / 转化医学Rare Adult Tumors, Rare Lymphomas
Alex Herrera
MD
🏢City of Hope🌐USA
Chief, Division of Lymphoma
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Alex Herrera leads trials in rare lymphoma subtypes including peripheral T-cell lymphoma and relapsed Hodgkin lymphoma. He co-led the SWOG S1826 trial establishing nivolumab-AVD for advanced Hodgkin lymphoma. His work integrates novel agents and cellular therapy for rare lymphoid malignancies.
Share:
🧪Research Fields 研究领域
rare T-cell lymphomas
Hodgkin lymphoma
checkpoint inhibitor lymphoma
brentuximab
cell therapy lymphoma
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Alex Herrera 的研究动态
Follow Alex Herrera's research updates
留下邮箱，当我们发布与 Alex Herrera（City of Hope）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment